Tune in to the latest episode of the IQVIA SFE Insights Podcast as Lakshdeep Singh, Senior Principal at IQVIA, and Goksu Dogan, Senior Principal in the Artificial Intelligence and Machine Learning Solutions team, explore the role of predictive analytics and real-time triggers in optimizing HCP engagement and improving patient outcomes. Discover how AI/ML-powered solutions are revolutionizing the pharmaceutical industry and providing actionable insights that drive better business results. Don't miss this insightful discussion!

IQVIA Vice President for Clinical Operations Gjon Mirdita who oversees site management in the EMENA region shares his impressions on clinical operations from his recent visit to Egypt and Saudi Arabia, including the potential of clinical operations in these countries and the Middle East as a whole, IQVIA's work and cooperation with stakeholders in the region, and the development and growth of the teams and the individuals.

In this episode, Dr. Vishakha Sharma, Senior Principal Data Scientist at Roche Diagnostics, shares her perspectives on the potential of Generative AI (GenAI) to improve patient outcomes, enhance the efficiency of healthcare delivery, and reduce costs. She also addresses some of the key issues surrounding data interoperability and data integration when dealing with diverse data sources and unstructured data. The discussion brings attention to the need for guiding principles and highlights the ethical frameworks released by the World Health Organization. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Vishakha Sharma, Ph.D., Senior Principal Data Scientist, Roche Diagnostics

Elyse Munoz, IQVIA’s US Director of Research and Insights, joins the podcast to discuss insights from the second paper of a three-part series, all about optimizing a US launch. Expect to learn about what impacts the optimization phase of a US launch: patient adherence, market access in the US context (and how it’s different from Europe), and direct-to-consumer advertising (prohibited in other major markets).

IQVIA's VP for Tech & Services Rauf Mohamed spoke with Johnson & Johnson Managing Director for Innovative Medicine in the Gulf Region Pedro Matos Rosa about lung cancer in the region. Pedro discussed the severity of lung cancer and its prevalence throughout the region, key stats and insights, the progress in the fight against this cancer, and initiatives in the region that are helping in the fight against lung cancer.

In 2023, the WHO and the World Bank recognized Egypt's remarkable achievement in eradicating hepatitis C. This podcast features a special guest, H.E. Dr. Mohamed Hassany, Assistant to the Minister of Health for Public Health and Presidential Initiatives in Egypt, who shares the nation's journey from having one of the highest incidence rates of hepatitis C to its successful elimination, and shares lessons and insights on how the strategy that was implemented can be adapted in other low- and middle-income countries.

In episode 8, IQVIA EMEA Thought Leaderships’ lead on patient engagement, Meike Madelung, joins the podcast to talk about why patient engagement and support services (PES) are important for launch. Hear examples of how PES can benefit patients, healthcare systems, and pharma companies striving for launch success.

This podcast episode explores how data-driven solutions are transforming the healthcare industry. Our guest is Bob Forcier, a key figure at Smith and Nephew who plays a pivotal role in leveraging data for operational improvements. Bob shares insights on how Smith and Nephew define operational efficiency and the critical role OneKey data plays in achieving it. He and OneKey’s Charles Wallace, Associate Director Product Offering, discusses the integration process, quantifiable metrics, and the benefits of using OneKey data. Listen to the podcast to learn about Smith and Nephew’s success story and how OneKey has streamlined their operations.Featured speakers:Charles Wallace, OneKey Associate Director Product Offering, IQVIABob Forcier, Director, Smith and Nephew

Omnichannel is now a top priority for most pharma brand and commercial leaders. There’s a clear focus to embed omnichannel engagement and drive differentiating, consumer-like experiences within campaign plans and brand strategies. And while every organization is at a different maturity level, at IQVIA, we have seen a common trend that progress, regardless of your maturation, is harder and more limited than ever. In this podcast, IQVIA’s Matthew Smith and Matthew Doyle host a roundtable discussion with Takeda’s Chris Weber, Head of Customer Experience, U.S. Oncology, Julia Allen, Product Marketing Director, from Fresenius Medical Care, and Eisai’s Jared Shechtman, Marketing Technology Solutions, who share their unique perspectives on where the pharma industry currently stands with omnichannel transformations, the challenges related to execution, and what’s needed to be more successful in 2024 and beyond.

In today’s complex healthcare landscape, understanding your customers is more challenging than ever, and as such, medical device and diagnostic line partners face significant gaps and unmet needs for their commercial teams. IQVIA’s latest solution, the MedTech Market Activator, fueled with OneKey data, empowers commercial teams with comprehensive insights and tools to support strategic growth and daily activities. Tune in to this podcast to learn from data and product experts about how the MedTech Market Activator will provide your teams the agility needed to make a greater impact.Featured Speakers:Shauntell Kelley, Director of OneKey Product and Strategy, IQVIAChristian Brilliant, Director and Product Owner of MedTech Market Activator, IQVIA MedTechHarry Tomaszewski, Solutions Specialist, IQVIA MedTech

In episode 2, we examine financial assistance or case management: What is a case management approach and the importance of looking at the whole patient journey. 

In this episode, we examine the needs of patients in the current health systems and the role and potential of patient support programs to improve patient access to reliable and innovative treatments.

Tune in as Paige Desmarais, IQVIA SFE Principal, and Ruoxin Li, IQVIA Sr Director in Advanced Analytics, delve into the transformative impact of AI and machine learning on healthcare analytics. In this episode, they explore how these technologies are reshaping provider referral patterns. As patient and provider journeys become increasingly complex, analytics managers and brand product managers seek innovative strategies to identify referral networks more effectively.

Clinical trials play a significant role in the development of drugs and medical breakthroughs. They are key for the advancement of medicine, although not all stakeholders are aware of their of their strong impact on patient care. Listen to our podcast with guest speaker Dr. Nawal Al-Kaabi Senior Advisor and Consultant, Pediatric Infectious Disease at Sheikh Khalifa Medical City who will walk us through the landscape of clinical trials in the UAE and the region, with a focus on the COVID-19 clinical trial program.

IQVIA’s Vice President for Genomics and Precision Medicine Joanne Hackett discusses the importance of connected care, digital maturity, and innovation and technology in healthcare.

In this episode, Dr. Shelly Nash, Senior Vice President and Global Chief Medical Information Officer at Fresenius Medical Care, discusses the importance of health equity and access to care in driving better health outcomes. Dr. Nash defines the issue of health equity and shares initiatives and opportunities for medical device and diagnostic companies to accelerate progress and address hurdles along the way. Key highlights include the challenges of data integration and interoperability. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Shelly Nash, DO, FACOOG, Senior Vice President, Global Chief Medical Information Officer, Fresenius Medical Care

Learn about the progress and challenges facing the Expanded Program on Immunization in Nigeria.

In this episode, Sarah Rickwood and Stefan Lutzmayer discuss key findings from the “From Orphan to Opportunity: Mastering Rare Disease Launch Excellence” white paper. Discover how to navigate the complex rare disease landscape, overcome post-pandemic hurdles, and apply the three pillars of launch excellence to achieve success in rare diseases.

This episode focuses on Patient Centricity in Design and how engaging patients in protocol design can improve clinical outcomes. IQVIA’s Patient Centricity in Design solution helps sponsors optimize study design for patient engagement and patient outcomes, such as incorporating diverse patient preferences, selecting design elements that align with real-world patient experiences and using this knowledge to minimize patient burden. Ivan Petrov, Associate Design Analytics Director is our featured speaker.

In this episode, IQVIA’s Raj Stewart and Michelle Edwards dig deeper into IQVIA’s annual “Ten MedTech Trends to Watch” report, which focuses on the key trends impacting the U.S. MedTech industry today. Learn how health equity, the consolidation of health systems, and advances in diagnostics are impacting the need for evidence generation among MedTech manufacturers and suppliers.Read Ten MedTech Trends to Watch in 2024 to learn more. Host: Michaela Miller, Practice Lead, U.S. MedTech Technology & Analytics, IQVIAFeatured Speakers: Michelle Edwards, Practice Lead, U.S. MedTech Real World and Clinical Solutions, IQVIARaj Stewart, Principal, MedTech Market Access, IQVIA

Sarah Rickwood is joined by Elyse Muñoz, IQVIA’s US Director of Research & Insights, to discuss the first of a three-part launch excellence series on the current state of US launch and the new rules for launching excellently in the US, the most important market for global innovative medicines success.

Dive into the world of data management with “Consumer Health Edge” podcast’s latest episode, “Mastering Data; A Beginner’s Guide to Information Management.” Join host Vaishnavi Save as she welcomes Antonello Moscatelli, a seasoned expert with nearly two decades of experience in Data and Analytics. Together, they explore the crucial steps organizations must take to implement effective information management strategies. From aligning data strategy with business objectives to assessing the data landscape and ensuring security and compliance, this episode offers actionable insights and practical tips. Discover how to harness the power of data to drive informed decision-making, enhance efficiency, and gain a competitive edge in today’s dynamic market landscape. Tune in and empower your organization with the knowledge to unlock the full potential of your data assets.

Dr. Larisse Prinsen provides an overview of challenges, changes required, and implications of the NHI, from a legal perspective.

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into the first of our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.

Rare Diseases, though individually uncommon, collectively affect a significant number of people. In the Middle East, these conditions present a unique set of challenges and opportunities. Tune into our 2-part podcast as we uncover how the Middle East is tackling these uncommon conditions and shed the light on what rare diseases mean to the region, from healthcare challenges to the latest advancements.

In Episode 2 of our Consumer Health Edge podcast, Vaishnavi Save and Ankit Gupta delve into the dynamic world of data-driven customer journeys, sales, and distribution. We uncover the pivotal role of data analytics in optimizing shelf space for consumer health companies, suggesting how tools revolutionize in-store strategies. Understanding the consumer journey is paramount, with insights gathered from loyalty programs, social platforms, and primary market research. We explore the meticulous process of cleansing and storing data, essential for extracting actionable insights through diagnostic, descriptive, predictive, and prescriptive analytics. Moreover, we unravel the nuanced landscape of sales and distribution optimization, where data empowers companies to fine-tune their strategies, maximize revenue, and identify growth opportunities. Join us as we unravel the intricate web of data-driven healthcare strategies, offering a glimpse into the future of the industry.

Prof. Nicholas Crisp discusses South Africa's National Health Insurance, its potential, the reforms, changes, challenges, and the roles of the public and private sectors.

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This is part 2 of our conversation with Jason Patterson, Chief Analytics Officer at Publicis Health Media. This time, host Andrew Burkus, leads an insightful discussion on the future of measurement and optimization, the role AI may play in this evolution, and how all these elements will continue to drive better health outcomes. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence

IQVIA invited Eric Grant, the Communications and Media Manager for the Union for International Cancer Control (UICC), to delve into the critical issue of the cancer care gap in low- and middle-income countries (LMICs) across the Middle East and Africa, shedding light on the challenges these countries encounter while striving to bridge this gap and the efforts being made.

Prof. Roseanne Harris, Health Policy Actuary at Discovery Health, discusses South Africa's National Health Insurance, its potential, the reforms and changes, and the roles of the public and private sectors.

Welcome back to IQVIA Digital Enablement’s podcast series: Personalization Science. This week, we are joined by Jason Patterson, Chief Analytics Officer at Publicis Health Media, a top healthcare media agency built for the modern marketplace. In part 1 of this conversation, host Andrew Burkus and Jason dive into the world of healthcare media optimization, misconceptions in the industry, and how continuous optimization differs from campaign measurement. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence 

IQVIA South Africa General Manager Sandri Yssel presents an overview of the South Africa National Health Insurance Program and the podcast series.

Welcome to the inaugural episode of IQVIA Digital Enablement’s new podcast series focused on Personalization Science. Host Andrew Burkus, Sr. Principal, is joined by Amanda Powers-Han, Chief Marketing Officer at Greater Than One, a leading marketing communications agency dedicated to healthcare. Tune in as these industry experts define what personalization is, why it is essential for your audience engagement strategy, and how to drive better outcomes in healthcare and life sciences marketing. Learn more about IQVIA Digital Enablement here: https://www.iqvia.com/locations/united-states/solutions/digital-enablement-center-of-excellence

"Essentially, this allows our clinical researchers to improve the chances of success for the trial leading to faster, more efficient drug development… Ultimately, this is going to benefit patients.”Greg Lever is speaking about the use of flexible modeling to allow real-time changes to be made to clinical trial design and processes. As a director within the IQVIA Applied Data Science Center, and with over a dozen years of experience in the field, Greg knows the importance of data and advanced analytics in generating accurate patient insights to underpin key trial decision-making.By making clinical trials more patient friendly, he states, the more likely it is that research organizations will be able to attract and retain the participants they need to bring life-saving treatments to patients.In this podcast, Greg outlines how modeling can be used to enhance the entire patient journey, from the initial giving of informed consent right through to the trial’s close.

What if clinical trial sites could focus entirely on research? What if sponsors could have immediate access to trial patients during and after the study, and use those insights to improve trial design? What if all of that could be done without burdening an already strained site? What if those didn’t have to be “what ifs”?  In this sponsored episode of The Top Line, Julia Douthart talks to Jessica Jones, Director of Strategic Technology Delivery and Experience Optimization at IQVIA, about how new technologies are changing clinical trials, reducing the administrative burden on staff and improving insights for sponsors.But can it be done without adding an additional technological burden and learning curve on the site staff? Listen below to learn how IQVIA is addressing these challenges.

In this episode, Sarah Rickwood and Kirstie Scott discuss key findings from the “Success Multiplied: Launch Excellence for Multi-Indication Assets” white paper. Learn about the specific challenges multi-indication assets face, such as sequencing and speed of indication roll-out, performance consistency across multiple indications and promotional investment strategies to capture pan-indication synergies.

In part two, Andrew Jones shares just how much data is available in IQVIA’s Infinite Dimension Profiler. Tune in and learn how you can build healthcare professional profiles that include both professional and personal dimensions. He also shares how the platform opens up data silos, relieving IT headaches, and allows you to build true omnichannel programs. If you missed part one, catch up for an overview of the Infinite Dimension Profiler.   Featured Speakers:Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA Andrew Jones, Product Manager, Global Information Management, IQVIA

Do you have a complete picture of the healthcare professionals (HCPs) in your universe? Are you able to dynamically target and message them as market events change? If you don’t, or even if you think you do, tune into this podcast where IQVIA’s Kathleen Aalderink and Andrew Jones discuss all things around joining and leveraging data to build and compare target audience profiles. You will hear how the Infinite Dimension Profiler will help you pinpoint the right HCPs, which in turn, increases the speed in which your therapies reach patients. Be sure to tune into part two; you’ll be impressed to hear about the incredible amount of data you can have at your fingertips.Featured Speakers:Kathleen Aalderink, Director, OneKey Digital Enablement, IQVIA Andrew Jones, Product Manager, Global Information Management, IQVIA

This final episode focuses on the authority of physician assistants and naturopathic physicians. The conversation goes beyond the latest state-level authority regulations and includes a sampling of the varying definitions of what a naturopathic physician is. The speakers also share insight into what you can expect around prescriptive authority in the future. Be sure to tune into this episode, but to get the most out of our Prescriptive Authority series, take the opportunity to listen to parts one and two as well. Featured Speakers: Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIALiz Updike, Director & Sr. Managing Attorney U.S. Client Services, IQVIA

Dive into the world of data-driven healthcare in the inaugural episode of "Consumer Health Edge." Join host Vaishnavi Save and industry expert Raj Jawalkar, with over two decades of experience, as we explore the game-changing role of predictive analytics. Discover strategies for sustainable success, the importance of a well-defined business objective, and the critical pillars of data transformation. Raj unravels the complexities of sourcing, processing, and integrating data for effective predictive models.Raj also provides insights into customer analysis for diverse industry groups—sales, pharmacies, marketing, and e-commerce. Learn how companies leverage predictive models to enhance effectiveness and drive strategic decisions in these domains.This episode speaks about the foundations of successful predictive analytics, offering tangible examples and expert insights. Don't miss out on this engaging discussion that unveils the intricate world of data-driven healthcare and its transformative impact on sales and marketing.Tune in now for a journey through the evolving landscape of consumer health!

Eric Klaver, DCT Regulatory Director, shares how IQVIA supports investigators within the areas of clinical trial conduct and operations.

IQVIA’s Head of Medical Affairs Strategy, Reinhard Berkels, joins Sarah Rickwood on the podcast to discuss the expanding role of Medical Affairs in launch. Hear how Medical Affairs is evolving and emerging as a more strategic function which can make or break a launch, and why this means companies should re-evaluate the way medical is positioned within their organization.

In part two, Jerrad and Shauntell dive into to topic of data consistency and the consequences it has on on and offline communications. When you start with the best possible reference dataset, marketers can identify and enrich the proper HCP target profiles. We then explore how this same dataset can be used to enable a host of connected digital channels as well as empower your sales force. By keeping the data consistent across both digital and in-person channels, the results of marketing and education efforts can be precisely measured and optimized. Towards the end of the conversation, they share their professional insight into the future of data. Don’t miss out, tune in now!Featured Speakers:Jerrad Rickard, Sr Dir, Product & Strategy: Email and OneKey Digital Enablement, IQVIAShauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIA

During this two-part series we will cover what creates a great digital experience for healthcare providers, which will allow them to create a great patient experience. In part one we will discuss the changes in the world of compliance, the latest complexities around master data management, and the need for a greater understanding of the patient journey. Explore all of these topics in an exceptional 20-minute episode!Featured Speakers:Jerrad Rickard, Sr Dir, Product & Strategy: Email and OneKey Digital Enablement, IQVIAShauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIA

In Episode 3, Sarah Rickwood interviews Cristina Alzaga-Chaudhry, IQVIA’s EMEA Lead of Commercial Strategy & Transformation. Learn about agile launch planning, how launch performance management has evolved, and leading edge key performance indicators.

During part two of the Prescriptive Authority series, the discussion focuses on the legislation that is driving changes affecting optometrists and psychologists. Tune in to learn how the changes affect the type of data you should be leveraging to help insure you remain compliant. Featured Speakers: Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIALiz Updike, Director & Sr. Managing Attorney U.S. Client Services, IQVIA

AI for R&D: Episode 3 | Leveraging AI/ML to better predict an asset's success Featured Speaker: Greg Lever, Director of R&D Solutions, Applied Data Science Center, IQVIA Host: Susan Cokas In this episode: See why integrating AI/ML into your operations will enable you to uncover deeper insights, make better informed clinical development decisions and realize competitive advantage Understand how AI-powered analytics can optimize your clinical development strategy Learn how data from different sources can be harmonized to provide a holistic view of a clinical development pathway and baseline success rates Thank you for joining us for our leadership podcast around IQVIA’s Artificial Intelligence and advanced analytics for research and development. We look forward to sharing even more insights on how data science is being applied to augment and accelerate the R&D process in future episodes.

During this episode, IQVIA subject matter experts will share insights around the recent trends in prescriptive authority. Their conversation will be centered on the legislation driving the changes, what the changes are, why the changes are occurring, and how you can comply with the regulations.Featured Speakers: Shauntell Kelley, Associate Director, Digital Solutions Offering Management, IQVIALiz Updike, Director, Client Services, IQVIA

In this episode, Cal St. Denis, Global Director of Sustainability at Johnson & Johnson MedTech, discusses the importance of implementing sustainability agendas that build in sustainability initiatives and considerations at the front end in product design all the way through to packaging. Cal shares part of Johnson & Johnson’s sustainability journey and highlights how MedTech industry customers are evolving and now demanding insights into respective sustainability agendas. Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Cal St. Denis, Global Director, Sustainability, Johnson & Johnson MedTech

As life sciences companies continue to prioritize new, omnichannel-centric commercial and customer engagement models, the ability for small and emerging biopharma organizations (EBPs) to be nimble and agile (relative to larger pharma companies) presents a potential advantage. Because many of these organizations are not as constrained as some of their larger peers by the complexities of existing size and scale, there is an opportunity to develop these new models more quickly and effectively. However, to date, too few EBPs have truly excelled in this space. IQVIA’s Susan Kitlas, VP, Precommercial Team, and Frank Papaianni, VP, Small Pharma, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to identify both leading practices and sensible first steps small and EBP organizations can take on their customer engagement model journeys in this episode of our Agile Brand Promotion podcast series.

This episode focuses on design analytics and how they can be used to assess study design decisions and identify risks prior to protocol approval. Knowing that a high number of protocols require at least one substantial, costly amendment— investing in optimizing your protocol upfront by applying design analytics is a great solution to reduce risk and ultimately increase the probability of success of your trial. Tammie Nguyen, Clinical Planning and Design Analytics Director is our featured speaker.

Sarah Rickwood and Kirstie Scott return in Episode 2 of the new Launch Excellence podcast series to discuss in more detail what companies should focus on in the challenging post-Pandemic environment. Expect to hear about the Three Pillars of post-Pandemic Launch Excellence and the elevated importance of healthcare system readiness to address the growing gap between the healthcare system preparation needs of many new launches and the ability of overstretched healthcare systems to meet those needs.

Sarah Rickwood and Kirstie Scott kick off the new Launch Excellence podcast series with a preview of their new white paper, Launch Excellence VIII. The authors discuss the evolving launch environment, post-Pandemic underperformance, resilient launches, and the latest insights on whether the "six-month window" holds in the challenging post-Pandemic environment.

Biopharma organizations are continuing to grow and invest in new customer-centric and omnichannel engagement models, and show no sign of slowing down. The pandemic has increased HCPs' digital maturity and comfort levels, while accelerating life sciences companies’ investment in and adoption of digital and virtual channels. HCPs now want more choice and flexibility regarding when, where, and how organizations interact with them. In this podcast, IQVIA’s host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, is joined by Arooba Marks, Customer Experience Lead at Pfizer Connect, Rich Palizzolo, Executive Director, Customer Experience at Sobi North America, and Alison Tapia, Sr. Director, Performance Marketing and Digital Innovation at Dermavant, to discuss and explore some of the common challenges and pitfalls companies face, lessons learned, and insights from efforts in the market. Other key topics include what’s working, keys to success going forward, and other industry perspectives from various functional domains.

IQVIA’s Hari Rayapudi and a group of guest speakers are back for part two. They will be sharing their perspectives around the challenges and interpreting specialty and rare disease data to ensure that there is alignment on insights. We will discuss technical challenges, systems platforms, and standards.Featured speakers:Hari Rayapudi, Senior Principal, Specialty Data Strategy and Consulting Services, IQVIAJourdan Masullo, Sr. Director, Patient Services, Kyowa KirinNatasha Mayfield, General Manager, Optum Frontier TherapiesJessica Mourani, Director, Clinical Outcomes, Trellis RxUmang Thaker, Director, PSS Oncology Strategy & Management, Novartis

In this episode, we will discuss how the specialty and rare disease ecosystems are evolving with new modes of care delivery, patient-centric programming, and expanding data sources.In part one, we will talk specifically about barriers to patient access and brand strategies to overcome these challenges and share a well-rounded view of the current specialty and rare disease environments. Joining IQVIA’s Hari Rayapudi is an incredibly talented group of industry leaders in specialty patient care for broad, specialty, and rare disease brands.Featured speakers:Hari Rayapudi, Senior Principal, Specialty Data Strategy and Consulting Services, IQVIAJourdan Masullo, Sr. Director, Patient Services, Kyowa KirinNatasha Mayfield, General Manager, Optum Frontier TherapiesJessica Mourani, Director, Clinical Outcomes, Trellis RxUmang Thaker, Director, PSS Oncology Strategy & Management, Novartis

In this episode, industry experts from IQVIA and Databricks talk about common information management challenges and opportunities for life sciences organizations to streamline their approach to data pipeline management and accelerate drug development and delivery as they undergo the necessary transformation modern healthcare demands. We will discuss how our partnership with Databricks can enable faster data ingestion, quicker time-to-insights, and cost reductions, as well as highlight success stories of companies who have already simplified their data governance and improved patient outcomes.Speakers:Bill ZaninePractice Leader Data Warehousing & Data Science, IQVIAMichael SankyGlobal Industry Lead for Healthcare & Life Sciences, DatabricksKatie LaughlinGlobal Head, Offerings Human Data Science Cloud, IQVIA

In episode two, IQVIA subject matter experts from the Channel and Specialty Data Services and Compliance teams will address a group of frequently asked questions around the topic of Suspicious Order Monitoring (SOM) and share some of their insights and real experiences. If you missed episode one, tune in to hear the team talk about Title 21 CFR 1301, the importance of size, patterns and frequencies, and how to use the appropriate and proper data. Plus, the tools that exist to help you stay compliant.  Featured speakers:Heather Kinney, Director, Offerings Management, IQVIAPaul Hamby, Senior Director, U.S. Regulatory Compliance Solutions, IQVIAKim Randolph, Associate Director, Product Management, IQVIAEric Brantley, SOM Engagement Manager, IQVIA

In this episode, IQVIA Channel and Specialty subject matter experts with members of IQVIA’s Compliance team discuss Suspicious Order Monitoring (SOM). Their conversation focuses on how, in recent years, laws have expanded, adding new legal requirements necessitating existing processes to adapt for manufacturers and distributors to remain compliant while distributing controlled substances. Listen in to gain a better understanding of the updated legislation, new requirements, and supportive data and existing tools that can help you stay compliant.  Featured speakers:Heather Kinney, Director, Offerings Management, IQVIAPaul Hamby, Senior Director, U.S. Regulatory Compliance Solutions, IQVIAKim Randolph, Associate Director, Product Management, IQVIAEric Brantley, SOM Engagement Manager, IQVIA

The launch environment has shifted significantly in the past few years, as it is increasingly more difficult and expensive to reach prescribers. While evolving challenges, including changes in the relative importance of launch stakeholders and the rise in patient-centricity, accelerated due to COVID-19. Although face-to-face interactions between sales representatives and healthcare professionals remain a core tenant of a brand's marketing and sales strategy, omnichannel promotion is growing in importance. As the healthcare ecosystem settles into a new equilibrium, the definition of success has shifted. In this episode of our Agile Brand Promotion podcast series, Nadine Vangelov, Sr. Principal, Launch Center of Excellence, and Daniel Luft, Sr. Principal, Brand & Commercial Strategy, join our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, to discuss how the success criteria for launch have evolved, how to define and prepare for success in this new era, and then explore how to enable more agility within and beyond the crucial first months of launch.

Our host, Matthew Smith, Sr. Principal, New Commercial Models & Digital Health, IQVIA, is joined by Madhavi Ramakrishna, Global VP of Cx, Data, Digital and Omnichannel at GSK, and Indraneel Mukherjee, a Sr. Principal in IQVIA’s strategy consulting group, to explore the future of customer experience and omnichannel for biopharma. In this episode, our experts dive into the reasons why during the pandemic, most biopharma organizations invested significantly in their virtual and digital marketing channels, systems, and technologies – many instances trying to scale them almost overnight. They discuss that most companies recognize this as a priority and have programs in flight to modernize their ecosystems, generate the necessary customer insights, and upskill their people to be able to “deliver omnichannel.” Most importantly, the panel looks into the future (5+ years from today) – where do we want to be and what needs to be true to get there?

In this episode of our Agile Brand Promotion podcast series, IQVIA’s Christie Conn, VP, Brand & Commercial Strategy, Jave Castillo, VP, CSO Strategic Solutions, and Kirk Harmon, VP, Contract Sales, join our host, Matthew Smith, Senior Principal, New Commercial Models & Digital Health, for an in-depth panel discussion on Agile Deployment for Modern HCP Engagement. In this podcast, our experts explore the various ways in which commercial pharma leaders are looking to balance innovative specialty launches with their existing revenue generators in an increasingly pressured access environment. Additionally, the panel discusses how, with today’s demands, it’s critical that commercial pharma leaders ensure that their biggest investments – field teams – are enabled to deliver the right message, at the right time, to the right customer, in order to keep HCPs engaged.

Today, the clinical trial operations industry is experiencing exponential growth in the use of devices, however, making sure these devices are optimized for trial use poses some challenges. In this podcast with Mike Bruhns, Director of Supplier Services from IQVIA, discover why it is important to find a device that meets the needs of a clinical trial.

Digital Health Technologies are becoming crucial as clinical trials become more patient centric, but they pose challenges that must be considered. Learn more by listening to this podcast from the Global Head of Connected Devices at IQVIA, Jeff Noll.

Creating a smart data strategy, with streamlined data collection and compliant reporting, requires strategic solutions that are automated, flexible, and fit-for-purpose. Selecting a device that fits both a trial and a data strategy can present a challenge for sponsors. Learn more by listening to this podcast from IQVIA leader Jacinta Rodrigues.

In this episode, join the Analytics Insights and Reporting (AIR) team as they discuss their participation in the recent Gartner Conference. Gartner is a consulting organization that conducts research on technology and then shares the results through both private consulting and executive-level programs and conferences. The AIR team will share their insights and takeaways from the three-day event and review how IQVIA can leverage key themes to better enable data and analytics within healthcare life science organizations.Featured Speakers:John F. Jackowski III, MBA LSSGB, Product Owner, Analytics, Insights, and Reporting, IQVIAMarlin Strand, Principal, Enterprise Business Intelligence, Analytics, Insights, and Reporting, IQVIAAndy Barnes, Principal and Commercial Analytics Consultant, Analytics, Insights, and Reporting, IQVIA

In this episode, we continue the discussion of product data management and include details around what type of product data management system may be the best fit for your organizational needs. We also focus on the types of problems that can be alleviated with each type of system, how the systems can complement each other, and why it is acceptable to have more than one type of system deployed to fully address your business and technical requirements.Featured Speakers:Jay Dzwil, Director and Solution Architect, IQVIAMichael Selvaggio, Technology Principal and Solution Architect, IQVIA

In this episode, Catherine Ellis and Raj Stewart of the IQVIA MedTech Commercial Consulting Team discuss a selection of key trends impacting the U.S. MedTech industry today. Take a deeper dive into the drivers of the recent direct-to-consumer advertising growth, hear how market access trends are going to impact the diagnostics market, and learn how labor shortages in healthcare are driving MedTech companies to innovate.Read Ten MedTech Trends to Watch in 2023 to learn more. Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIAFeatured Speakers: Catherine Ellis, VP, Practice Lead, U.S. MedTech Consulting, IQVIARaj Stewart, Principal, MedTech Market Access, IQVIA

In this episode, we discuss current trends in the data governance space for the life sciences industry, focusing on changes in the last 12-24 months on how companies are approaching management of their critical data assets with a more structured methodology. We also speak on how critical it is to manage your data correctly, the business processes tied to the data, and the potential to leverage data intelligence platforms to support this effort.Featured Speakers:Jay Dzwil, Director and Solution Architect, IQVIAPhyllis Imparo, Practice leader, Data Stewardship, IQVIA

Part two of the product data management discussion covers the challenges of globalization and hierarchy management that are frequently encountered by life sciences organizations, and how a product data management solution can be used to alleviate many of them. The goal is to help listeners become better versed in what an optimal product data management solution can mean for their organization.Featured Speakers: Jay Dzwil, Director and Solution Architect, IQVIAMichael Selvaggio, Technology Principal and Solution Architect, IQVIA

Over the past several years, there’s been a marked increase in the volume of emerging biopharma (EBP) companies facilitating their own product launches. In today’s turbulent market, one of the ways that EBP leaders can make a difference in their launch success is focusing on investment optimization – making sure that they’re smart about how their limited resources (digital, field-force, etc.) are deployed. In this episode of our ongoing podcast series, Agile Brand Promotion for the Emerging Biopharma Market, Susan Kitlas VP, Precommercial Segment, joins our host, Matthew Smith, Sr. Principal, Consulting Services, for an in-depth discussion on new commercial models for the EBP market.

In this episode, we begin part one of a product data management discussion to clear up some common misconceptions around various technologies (and their assorted acronyms) to help users become better versed in what optimal product data management can mean to their life sciences organization. This episode will better define what is meant by ‘the product,’ dig into the most frequently used data management technologies, and help clarify the role that each technology plays in the overall data management process. Featured Speakers:Jay Dzwil, Director and Solution Architect, IQVIAMichael Selvaggio, Technology Principal and Solution Architect, IQVIA

In this episode, Peter Bennett, Senior VP of Global Planning at Cardinal Health, discusses key components required to build a supply chain resiliency framework, the need for transparency and collaboration between MedTech product suppliers and distributors, the role of enhanced scorecards, and new approaches to demand planning/forecasting during times of uncertainty.Host: Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIAFeatured Speaker: Peter Bennett, CPIM, Senior VP of Global Planning, Cardinal Health

Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses how AI/ML is disrupting R&D across the board.  In this episode: How working in synergy with clinicians and research scientists, AI/ML can provide a much-needed augmentation to how drugs are developed.  Understand where to apply AI, whether it's early in drug discovery, to find the right patient subpopulations or to do disease modeling.  Explore using a machine learning approach based on fairness ranking systems to best represent a clinical trial patient base and address the challenge of diversity and inclusion. 

In this episode of the series “Selfcare Evolution”, IQVIA’s Omid Ashrafi is in conversation with everyday consumers to discuss their shift in shopping behavior pre and post COVID-19. Tune in to this exciting conversation to find out how consumers from across the Middle East are now shopping for OTC products. Get in touch with us here to learn more.

Our host, Matthew Smith, Senior Principal, Consulting Services, is joined by guests, Kelly Peters, Vice President, Marketing Center of Excellence, Andrew Burkus, Senior Principal, Client Success, Omnichannel Marketing, and Kristen Winters, Director, Pharma Digital Enablement, as they kick off their conversation by discussing what major challenges commercial pharma is facing as it relates to HCP engagement and how comprehensive, connected HCP data can provide solutions. Additionally, the panel explores the importance of campaign measurement, and how it goes hand-in-hand with campaign optimization, toward the goal of “continuous improvement,” both in terms of personal (face-to-face sales) and non-personal (digital) outreach efforts.

In the past, patient-level insights were achieved through time-consuming methods requiring substantial manual effort to produce static reports. With the help of technology and machine learning, that’s no longer the case. Dynamic reports and dashboards can provide faster answers to questions that go beyond the original report, while also allowing team members to ask their own questions. With dynamic reports, team members can share information freely without the manual drag of pulling data or static reports and performing manual queries to get what they need.  Join Andy Burch and Brian Smith, two thought leaders with a breadth of experience in AI-ML solutions, as they dive into the benefits of bringing automated data into dynamic visualization products and how they can help you develop deeper insights, faster, while improving team engagement.  Brian and Andy outline several ways dynamic reports are superior to static reports, even helping to foster a data-driven culture. Knowing at your organisation who is asking the questions about your brand performance, patient profiles, or key physicians in your market, when are they asking the questions, how up to date does the data need to be? All this can feed into a highly customised dynamic delivery rather than only being able to ask questions once in a static delivery model. 

Real world data (RWD) and artificial intelligence (AI) offer an unprecedented opportunity for Medical Affairs professionals to understand and share deeper insights about patients, including insights regarding disease progression, outcomes, and treatment response, as well as additional insights about patients’ journeys prior to diagnosis and after treatment initiation.  Cindy Weber of IQVIA’s Artificial Intelligence Solutions team explains how embracing RWD and AI technology, and the opportunities they provide, is helping to transform Medical Affairs, making it more impactful. By leveraging new insights, Medical Affairs professionals can foster better, more meaningful, connections with healthcare professionals, while also making important new contributions to improving patient care. Cindy provides specific examples of the kinds of insights AI and RWD are providing today and makes specific suggestions for how your Medical Affairs team can move forward in this new, exciting direction.  

On this short taster for an upcoming IQVIA Consumer Health webinar, The Next Wave of Self-Care Digital Health, Dr. Volker Spitzer and Swapna Kondapuram discuss how the consumer health industry can apply digital health technologies, the most relevant areas the industry should be paying attention to, and where they think the value in investing in digital health really lies. They then close off the session by taking a look into the future of digital health.

In 2020, scientists working on injury analytics expanded to COVID-19 epidemiology to help create and monitor the NBA bubble. Dr. Christina Mack, an epidemiologist with IQVIA Real World Solutions, talks with Dr. Josh Sharfstein about how the team continues to monitor the health and safety of players and staff, and some of the findings with real-world implications such as how long people can shed COVID-19 virus, if people with asymptomatic infections are less likely to transmit COVID, and whether boosters really work.

In this episode of the series “Selfcare Evolution”, IQVIA’s Adhiti Kumar is in conversation with Ahmed Elsayyad to discuss the impact of private labels on the OTC market. Get insights about the evolution of the OTC market in Saudi Arabia and learn more about the key growth drivers and challenges seen in the private label market. Get in touch with us here to learn more.

In this episode, Dr. Shannon Haymond, President of the American Association for Clinical Chemistry (AACC), discusses the highlights from the AACC Annual Scientific Meeting & Clinical Lab Expo held in Chicago, IL. Featured Speakers: Shannon Haymond, PhD, DABCC FAACC, President, American Association for Clinical Chemistry (AACC), Laboratory Director at the Ann and Robert H. Lurie Children’s Hospital of Chicago, and Associate Professor of Pathology at Northwestern University, Feinberg School of Medicine Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA

In this episode, Lena Chaihorsky, Co-Founder and VP of Payer Innovation at Alva10, shares insights on how to best engage with payers to secure value-based pricing for diagnostic tests and highlights areas of opportunities to increase success in a challenging reimbursement environment. The podcast references this article from The Journal of Precision Medicine. Featured Speakers: Lena Chaihorsky, Co-Founder and VP of Payer Innovation, Alva10Michaela Miller, Practice Leader, U.S. MedTech Technology & Analytics, IQVIA

In this episode of the series “Selfcare Evolution”, IQVIA’s Adhiti Kumar is in conversation with Mearal Hussien to discuss the economic changes and the regulatory pricing changes that took place in MENA and their impacts on the OTC market. We will highlight how multiple factors, such as an increase in supply chain is affecting the current economic situation and what companies are doing to address this. We will deep dive into the nature of the OTC industry and the steps they are taking to stabilize their market. Get in touch with us here to learn more. 

In this episode of the series “Selfcare Evolution”, IQVIA’s Sneha Keshav is in conversation with Dr. Sabih Shaikh*, to discuss the effect of the radical shift in consumer health companies and their adoption of a ‘Digital First Approach’ in their engagement with HCPs and patients. We will highlight how one of the leading consumer health companies made this shift while incorporating an omni-channel approach as a new way of working. We will also learn how success is defined and what are the key enablers of this.  Get in touch with us here to learn more. *Dr. Sabih Shaikh was part of Johnson and Johnson when this podcast was recorded. 

Communication has always been critical in the process of brand building as such in any industry, and it is becoming even more relevant in Consumer Health considering the increased exposure and reliance on self-medication. In this episode of Fostering Consumer Health, we will be talking to a very passionate brand builder and an experienced business leader, Ritu Mittal, who heads Marketing and Digital for Bayer Consumer Health and has played a pivotal role in giving a new life to a legendary brand like Saridon and further nurturing a growing brand like Supradyn. Tune in to this interesting conversation, where Ritu shares her perspective on healthcare consumerism, foundational pillars of consumerism and critical success factors behind Bayer Consumer Health’s recent successes and more to come.

In this episode of the series – The Self-care Evolution, IQVIA’s Consumer health expert, Omid Ashrafi, is in conversation with Dr. Mohamed Galal, Vice President - Head of Middle East, Bayer Consumer Health to discuss how the pandemic has led to a change in consumer buying behavior and has accelerated the adoption of newer channels. He also speaks about how the industry is shaping up to cater to consumer’s channel needs and regional challenges that the companies need to be cautious of while devising channel strategy.Get in touch with us here to learn more. 

Current methods of making decisions on drug assets are becoming antiquated, costing a lot of time...money...and unnecessary risk. Understanding the probability of technical and regulatory success (PTRS) for a given indication enables faster, smarter decisions while minimizing risk. Learn about the new Asset Intelligence tool, which validates R&D candidates through powerful AI-driven analysis and real-world data to forecast clinical trial outcomes, in this podcast.  

Yes, Gross to Net is big! During this wrap-up session, we introduce rebate exclusions, anti-kickback statutes, and financial SOX compliance controls into the conversation. The team sheds light on data integration as critical in pulling all the data together and pushing the analytics to the right people across your organization. Plus a few thoughts on the future of Gross to Net and how leveraging newer technology will help to build an even clear picture.

During this episode, the team digs into the hot topic of 340B. For many organizations, 340B has a negative impact on their Gross to Net. Tune in and learn about the effect discount stacking has on product pricing and service fees that are paid to specialty pharmacies and wholesalers. All effect your Gross to Net profit and calculations.     

In episode one, we share information about the general environment around Gross to Net, the impact it has on your business, and how to help maximize it for organization efficiency and profitability. Plus, insights for collecting and integrating together all the necessary data.

In this episode, we discuss digital twin technology and the value of computational modeling in healthcare with Dr. Steve Levine, Sr. Director of Virtual Human Modeling at Dassault Systèmes, and Founder of The Living Heart Project.

Digital transformation has always been widespread but with the COVID-19 pandemic, accelerated adoption of digital and remote capabilities such as self-tracking medical devices, virtual clinical trials and telemedicine have become more prevalent. Listen to the podcast to hear from IQVIA MedTech and Digital experts on the current industry trends, how MedTech companies can build their strategic roadmap to leverage their own digital capabilities in order to achieve digital maturity and successfully transform in this era and beyond. To learn more about digital transformation in MedTech, download our white paper here. 

While FMCG has been the early adopter of Digital Prowess, the pandemic has pressured many sectors to scale up their digital marketing capabilities, including consumer health brands. In this Episode of ‘Going the Digital Way’, IQVIA’s Consumer health expert Tina Khadloya is in conversation with Vijayaraghavan Venugopal, Co-founder and CEO of FAST&Up, who has been one of the early adopters of Digital Wave for a consumer health brand. Tune in to listen and understand why digital is even more relevant for consumer health and how to surf through this wave differently.

The promising technique of drug repurposing is gaining attention from across the pharma industry, not only for reducing time and cost, but also lowering risk in the process of developing drugs for cancers and other rare illnesses — ultimately getting life-saving treatments to patients faster. Nathan Sommerford, Global Lead of AI for Drug Discovery & Development at IQVIA, discusses the basics of drug repurposing and how this approach is rapidly expanding in this latest podcast.

In this episode, Navin Dewagan, President of Digital Health Solutions, and Michaela Miller, Practice Lead, Technology & Analytics at IQVIA discuss the importance of cybersecurity in the medical device space. Learn about the latest FDA guidance and how to incorporate cybersecurity into medical device management and product development strategies.

Often described as game-changing, artificial intelligence and machine learning technology is revolutionizing drug development and the pharmaceutical industry. See how you can leverage AI/ML to mine old drugs for new applications and bring treatments to patients faster – at lower costs – in this Leadership Podcast.